Vicks Nears $1 Bil. In Sales Under “Focused” Growth Strategy – P&G
This article was originally published in The Tan Sheet
Executive Summary
The Vicks brand of over-the-counter cough, cold and flu products is "on its way" to becoming a $1 billion franchise, according to Procter & Gamble President and CEO A.G. Lafley
You may also be interested in...
Prilosec OTC Part Of “Engine Of Growth” P&G Expects From Health Care Sales
Procter & Gamble's Prilosec OTC (omeprazole) reached nearly 40 percent market share in the firm's latest quarter to lead the OTC heartburn medication segment
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.